Robeco Institutional Asset Management B.V.
Position in LLY — ELI LILLY & Co
CIK 1418773
ROTTERDAM, P7
Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$910,055,594
+$309,311,498 QoQ
Shares Held
758,740
+16.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#88
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. LLY ranks #1 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
|
580,049 | $210,047,343 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $910,055,594 | 758,740 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $600,744,096 | 653,146 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $780,717,478 | 726,465 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $622,460,741 | 815,807 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $526,997,358 | 676,045 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $579,951,524 | 702,197 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $598,827,276 | 775,683 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $732,622,767 | 826,944 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $653,813,829 | 722,143 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $606,571,522 | 779,695 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $389,926,846 | 668,920 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $444,245,183 | 827,072 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $474,458,155 | 1,011,681 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $308,372,615 | 897,946 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $403,539,080 | 1,103,048 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $462,238,202 | 1,429,529 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $448,628,296 | 1,383,673 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $424,194,153 | 1,481,280 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $427,528,344 | 1,547,782 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $439,847,805 | 1,903,691 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $464,105,506 | 2,022,070 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $396,050,553 | 2,119,958 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $447,469,898 | 2,650,260 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $393,707,888 | 2,659,829 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $424,759,764 | 2,587,159 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $223,324,773 | 1,609,896 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||